This study investigates advanced metastatic pancreatic cancer. The purpose of this study is to evaluate a combination of investigational medications for this condition.
Researchers are assessing the safety and effectiveness of these investigational medications. The study focuses on understanding how well these treatments work for patients.
- Who can participate: Adults aged 18 and older with confirmed metastatic pancreatic adenocarcinoma can participate. Participants must have at least one measurable lesion and should not have received prior systemic anti-cancer therapy.
- Study details: Participants will receive investigational medications and undergo regular assessments. Some participants may receive a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.
How understandable was the trial content above?
Hard to understand
Easy to understand